Previous close | 0.1826 |
Open | 0.1900 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.1752 - 0.1900 |
52-week range | 0.1020 - 2.6200 |
Volume | |
Avg. volume | 39,941 |
Market cap | 18.165M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2800 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cybeats Technologies Corp. ("Cybeats'' or the "Company")(CSE: CYBT) (OTCQB: CYBCF), a Company offering industry-leading cybersecurity software, is pleased to report a contract renewal for its product, SBOM Studio1, with a Top 10 global Medical Device Manufacturer ("MDM") that has a $70 Billion USD market cap.2
Cybeats Technologies Corp. ("Cybeats'' or the "Company") (CSE: CYBT) (OTCQB: CYBCF), a company offering industry-leading cybersecurity technology, is pleased to provide an update on new cybersecurity regulation by the European Union's ("EU") Cyber Resilience Act ("CRA" or "Act"), which positions Cybeats to benefit from the enforcement of SBOM requirements.
Cybeats Technologies Corp. ("Cybeats'' or the "Company")(CSE: CYBT) (OTCQB: CYBCF), a Company offering industry-leading cybersecurity software, is pleased to announce a SaaS ("software as a Service") agreement for its SBOM Studio1 product with one of the largest European telecom providers, that has a $30 Billion market cap.